TCL Archive Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer August 27, 2010
TCL Archive FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic September 10, 1976
TCL Archive NCI Contract Process Requires Eight Months, Probably Will Get Longer As Program Grows February 8, 1974
